Getein Biotech Inc (603387) — Capital Reinvestment Ratio
Getein Biotech Inc (603387) has a Capital Reinvestment Ratio of 0.34x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥100.90 Million) in capital expenditures (CN¥34.34 Million). See how leveraged is Getein Biotech Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Getein Biotech Inc Capital Reinvestment Ratio (2012–2025)
This chart tracks Getein Biotech Inc's Capital Reinvestment Ratio across 14 annual periods. Check 603387 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Getein Biotech Inc (2012–2025)
Year-by-year Capital Reinvestment Ratio for Getein Biotech Inc from 2012 to 2025. For live market cap and broader valuation context, see market value of Getein Biotech Inc.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | CN¥392.59 Million | CN¥150.58 Million | ▲ +3.7% |
| 2024 | 0.37x | CN¥423.00 Million | CN¥156.40 Million | ▼ -52.3% |
| 2023 | 0.77x | CN¥333.22 Million | CN¥258.13 Million | ▲ +72.1% |
| 2022 | 0.45x | CN¥482.96 Million | CN¥217.44 Million | ▲ +8.4% |
| 2021 | 0.42x | CN¥432.36 Million | CN¥179.60 Million | ▼ -32.1% |
| 2020 | 0.61x | CN¥185.47 Million | CN¥113.53 Million | ▲ +10.7% |
| 2019 | 0.55x | CN¥225.73 Million | CN¥124.82 Million | ▼ -6.6% |
| 2018 | 0.59x | CN¥187.10 Million | CN¥110.74 Million | ▲ +85.2% |
| 2017 | 0.32x | CN¥191.91 Million | CN¥61.35 Million | ▲ +26.8% |
| 2016 | 0.25x | CN¥155.91 Million | CN¥39.31 Million | ▼ -34.2% |
| 2015 | 0.38x | CN¥121.73 Million | CN¥46.65 Million | ▼ -46.1% |
| 2014 | 0.71x | CN¥98.53 Million | CN¥70.09 Million | ▲ +253.3% |
| 2013 | 0.20x | CN¥59.72 Million | CN¥12.02 Million | ▼ -53.9% |
| 2012 | 0.44x | CN¥23.80 Million | CN¥10.39 Million | — |